CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)

South Korea flag South Korea · Delayed Price · Currency is KRW
942.00
+14.00 (1.51%)
Jul 3, 2026, 3:30 PM KST
Market Cap139.53B -57.5%
Revenue (ttm)110.12B +13.6%
Net Income-8.38B
EPS-58.08
Shares Out 148.12M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume382,583
Open929.00
Previous Close928.00
Day's Range924.00 - 954.00
52-Week Range853.00 - 2,255.00
Beta0.40
Analystsn/a
Price Targetn/a
Earnings DateApr 3, 2026

About CMG Pharmaceutical

CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutic... [Read more]

Sector Healthcare
Founded 2001
Employees 223
Stock Exchange KOSDAQ
Ticker Symbol 058820
Full Company Profile

Financial Performance

Financial Statements